These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23838572)

  • 21. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2010 Dec; 106(11):1561-5. PubMed ID: 21094355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vivo iMap IVUS comparison of in-stent neointima and native coronary atherosclerosis.
    Trusinskis K; Strenge K; Juhnevica D; Erglis A
    Cardiovasc Revasc Med; 2015 Jun; 16(4):233-6. PubMed ID: 25980925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of chronic kidney disease on a re-percutaneous coronary intervention for sirolimus-eluting stent restenosis.
    Aoyama Y; Hirayama H; Ishii H; Kobayashi K; Ishikawa K; Takigawa M; Nanasato M; Yoshida Y; Aoyama T; Yoshikawa D; Matsubara T; Murohara T
    Coron Artery Dis; 2012 Dec; 23(8):528-32. PubMed ID: 22975841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Everolimus-eluting stent for the treatment of bare metal in-stent restenosis: clinical and angiographic outcomes at nine-month follow-up of XERES (Xience Evaluation in bare metal stent REStenosis) trial.
    Carrié D; Delarche N; Piot C; Berland J; Menneveau N; Bonello L; Py A; Teiger E; Leborgne L; Bayet G; Wittenberg O; Schiele F
    EuroIntervention; 2014 Oct; 10(6):700-8. PubMed ID: 24334825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients.
    Deftereos S; Giannopoulos G; Raisakis K; Kossyvakis C; Kaoukis A; Panagopoulou V; Driva M; Hahalis G; Pyrgakis V; Alexopoulos D; Manolis AS; Stefanadis C; Cleman MW
    J Am Coll Cardiol; 2013 Apr; 61(16):1679-85. PubMed ID: 23500260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A severely calcified neointima 9 years after bare metal stent implantation.
    Yoshida K; Sadamatsu K
    Cardiovasc Revasc Med; 2012; 13(6):350-2. PubMed ID: 22898053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries.
    Waksman R; Erbel R; Di Mario C; Bartunek J; de Bruyne B; Eberli FR; Erne P; Haude M; Horrigan M; Ilsley C; Böse D; Bonnier H; Koolen J; Lüscher TF; Weissman NJ;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):312-20. PubMed ID: 19463443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local delivery of sirolimus nanoparticles for the treatment of in-stent restenosis.
    Zago AC; Raudales JC; Attizzani G; Matte BS; Yamamoto GI; Balvedi JA; Nascimento L; Kosachenco BG; Centeno PR; Zago AJ
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):E124-9. PubMed ID: 22566402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neointimal response to second-generation drug-eluting stents in diabetic patients with de-novo coronary lesions: intravascular ultrasound study.
    Won H; Kang TS; Hong BK; Lee S; Jeon DW; Ryu SK; Min PK; Yoon YW; Lee BK; Kwon HM; Ko YG; Jang Y
    Coron Artery Dis; 2015 May; 26(3):212-9. PubMed ID: 25426659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
    Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
    Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of IVUS guided bare metal stent implantation for non-small vessel.
    Kataoka T; Shimada K; Fukuda D; Nishioka H; Oda S; Ehara S; Hirose M; Kamimori K; Kobayashi Y; Yoshiyama M; Takeuchi K; Yoshikawa J
    Osaka City Med J; 2004 Dec; 50(2):79-86. PubMed ID: 15819302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does Carbofilm coating affect in-stent intimal proliferation? A randomized trial comparing Rx multi-link penta and Tecnic Carbostent Stents: SIROCCO Trial.
    Carrié D; Lefevre T; Cherradi R; Dumas P; Elbaz M; Finet G; Puel J; Morice MC
    J Interv Cardiol; 2007 Oct; 20(5):381-8. PubMed ID: 17880335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OCT analysis in patients with very late stent thrombosis.
    Kang SJ; Lee CW; Song H; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Mintz GS; Park SW; Park SJ
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):695-703. PubMed ID: 23643282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
    Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry.
    Yonetsu T; Kato K; Kim SJ; Xing L; Jia H; McNulty I; Lee H; Zhang S; Uemura S; Jang Y; Kang SJ; Park SJ; Lee S; Yu B; Kakuta T; Jang IK
    Circ Cardiovasc Imaging; 2012 Sep; 5(5):660-6. PubMed ID: 22798521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.